Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

EHRs need to be interoperable, secure and automated for healthcare to thrive, according to Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences. Here are five ...

Hazy skies laden with harmful particulates settle in every winter over vast areas of India such as this congested road in New Delhi.Credit...Vani Bhushan for The New York Times Supported by By Anurag ...

Dec 8 (Reuters) - Recursion Pharma (RXRX.O), opens new tab, which uses artificial intelligence to discover new drug candidates, said on Monday its experimental oral drug helped reduce abnormal growths ...

Aditya Madiraju went from a high-paying finance job to walking in Paris Fashion Week and filming beauty content for his 5 million followers across platforms fernando-rodriguez Aditya Madiraju started ...

After twelve years at the helm of AI-drug developer Recursion, Chris Gibson will hand the CEO baton to Najat Khan, PhD, the company’s chief R&D officer and chief commercial officer, effective January ...

Dave Guilmette, CEO of benefits solutions provider Alight, will step down at the end of the year and be replaced by Rohit Verma, who currently leads Crawford & Company, which provides insurance claims ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

Filmmaker Aditya Dhar is currently leading the headlines after the trailer of his latest film, Dhurandhar, created huge excitement among his fans. A spy-action thriller starring Ranveer Singh, Sanjay ...

Management reaffirmed guidance for 2025 on an expense base of less than $450 million, "excluding all of the partnership inflows." For 2026, guidance was also reaffirmed at less than $390 million.

Robinhood Markets Chief Financial Officer Jason Warnick plans to retire next year. Shiv Verma, who has been serving as treasurer and head of finance and strategy, is expected to succeed Warnick, the ...